Sexually transmitted infections (STIs) continue to pose a severe and under-recognized global health challenge. Asymptomatic in many cases, they spread unknowingly, resulting in serious long-term health issues—such as infertility, chronic pain, cancer, and enhanced HIV susceptibility. Women often bear the heaviest burden.
Conventional STI testing—plagued by multi-step processes, prolonged wait times, and operational complexity—has long been a critical barrier to timely treatment and effective prevention. Patients often endure frustrating cycles of clinic visits, repeat testing due to inconclusive or delayed results, and anxiety while waiting—sometimes for days—to receive a diagnosis. This drawn-out process not only increases the risk of unknowing transmission but also fuels stigma, discourages follow-up visits, and leads to treatment aversion. Many individuals, especially those in vulnerable or underserved communities, may even avoid testing altogether because of these systemic hurdles.
That’s where the Sample-to-Answer Protocol makes all the difference.
Introducing the 9-in-1 Genitourinary Tract Infection Pathogen Detection Kit from Macro & Micro-Test, run on the fully automated molecular POCT system AIO800. This integrated solution redefines simplicity and reliability in STI diagnostics.
From Sample to Result – Seamlessly Integrated
With a true sample-to-answer design, the AIO800 system streamlines the entire process—from original sample tube (urine, swabs) to final report—in just 30 minutes. There’s no need for manual preprocessing, reducing hands-on time and virtually eliminating contamination risks.
Post time: Sep-12-2025